石四药集团(02005.HK)：医用重组胶原蛋白妇科凝胶等两款医疗器械获河北药监局注册证

Core Viewpoint - The company Shijiazhuang Four Medicines Group has received medical device registration certificates for two products from the Hebei Provincial Drug Administration in China, indicating a significant step in expanding its product offerings in the medical device sector [1]. Group 1: Product Details - The medical recombinant collagen gynecological gel is designed to prevent the colonization of pathogenic microorganisms on the vaginal wall [1]. - The B-type natriuretic peptide (BNP) test kit is intended for the quantitative measurement of BNP levels in human plasma and whole blood samples, serving as an auxiliary diagnostic tool for assessing the risk of heart failure [1].